Why Galapagos Trounced the Market Today
A high-profile healthcare industry executive has been tapped as the company's new CEO.
GALAPAGOS NV SPON ADR REPR 1 ORD SHS
Symbol | Last Price | Market Cap | % Δ 1 Yr | % Δ 5 Yr |
---|---|---|---|---|
GLPG
Galapagos
|
$54.83 | $4B | -24.3% | -34.2% |
BHC |
$9.61 | $3B | -70.4% | -27.4% |
CRSP |
$54.71 | $4B | -54.7% | 240.6% |
CRLBF |
$3.90 | $2B | -65.0% | |
PACB |
$5.43 | $1B | -79.1% | 43.7% |
A high-profile healthcare industry executive has been tapped as the company's new CEO.
GLPG earnings call for the period ending September 30, 2021.
GLPG earnings call for the period ending June 30, 2021.
The company's new salt-inducable kinase inhibitor program is getting off to a rocky start.
GLPG earnings call for the period ending March 31, 2021.
Despite some serious setbacks, this beaten-down biotech could be a terrific bargain at recent prices.
GLPG earnings call for the period ending December 31, 2020.
The FDA dealt the biotech and its big partner a huge setback.
GLPG earnings call for the period ending June 30, 2020.
Binary events could send shares of these stocks screaming higher, or lower, soon.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.